Bahrain
Bahrain: Covishield vaccine interval extended to 8 weeks
![](/wp-content/uploads/2021/02/ON-EC763_Vaccin_GR_20201123055418-780x470.jpg)
Following recommendations from the WHO, Covishield-AstraZeneca dosing intervals have been extended from 4 to 8 weeks.
To increase vaccine efficiency and produce a strong immune response.